Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg
Jianfeng Liu, Jun‐Xu Li
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders
Thian‐Sze Wong, Guangzhi Li, Shiliang Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 60
Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia
Eric D. Achtyes, Seth C. Hopkins, Nina Dedic, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 7, pp. 1543-1556
Open Access | Times Cited: 29
TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding
Nina Dedic, Lien Wang, Éva Hajós‐Korcsok, et al.
Molecular Metabolism (2024) Vol. 80, pp. 101883-101883
Open Access | Times Cited: 8
Drug addiction: a curable mental disorder?
Jianfeng Liu, Jun‐Xu Li
Acta Pharmacologica Sinica (2018) Vol. 39, Iss. 12, pp. 1823-1829
Open Access | Times Cited: 68
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders
Urszula Kozłowska, Charles D. Nichols, Kalina Wiatr, et al.
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 89-108
Open Access | Times Cited: 52
Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry?
Seetal Dodd, André F. Carvalho, Basant K. Puri, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 120, pp. 537-541
Closed Access | Times Cited: 51
Trace amine signaling in zebrafish models: CNS pharmacology, behavioral regulation and translational relevance
David S. Galstyan, Natalia A. Krotova, A. S. Lebedev, et al.
European Journal of Pharmacology (2025), pp. 177312-177312
Closed Access
The TAAR1 Agonist PCC0105004 Regulates Amygdala Synaptic Plasticity to Alleviate Anxiety‐Like Behaviors in Rats
Y Zhang, Wei Zhang, Linyao Yu, et al.
Pharmacology Research & Perspectives (2025) Vol. 13, Iss. 2
Open Access
Taar1 gene variants have a causal role in methamphetamine intake and response and interact with Oprm1
Alexandra M. Stafford, Cheryl Reed, Harue Baba, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 30
TAAR1 and Psychostimulant Addiction
Jianfeng Liu, Ruyan Wu, Jun‐Xu Li
Cellular and Molecular Neurobiology (2020) Vol. 40, Iss. 2, pp. 229-238
Open Access | Times Cited: 30
Dimethyltryptamine: Endogenous Role and Therapeutic Potential
Alexandra VSL Rodrigues, Francisco Almeida, Maria Augusta Vieira‐Coelho
Journal of Psychoactive Drugs (2019) Vol. 51, Iss. 4, pp. 299-310
Open Access | Times Cited: 28
Metabolomics reveals biomarkers of opioid use disorder
Reza Ghanbari, Yuanyuan Li, Wimal Pathmasiri, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Amphetamine-type stimulants: Novel insights into their actions and use patterns
Miguel I. Paz-Ramos, Silvia L. Cruz, Valeria Violante‐Soria
Revista de investigaci�n Cl�nica (2023) Vol. 75, Iss. 3
Open Access | Times Cited: 8
TA 1 agonists attenuate extended‐access cocaine self‐administration and yohimbine‐induced reinstatement of cocaine‐seeking
Jianfeng Liu, Bernard Johnson, Ruyan Wu, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 15, pp. 3403-3414
Open Access | Times Cited: 22
TAAR1 and 5-HT1B receptor agonists attenuate autism-like irritability and aggression in rats prenatally exposed to valproic acid
Lien Wang, Erin Clark, Lynsey Hanratty, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 245, pp. 173862-173862
Closed Access | Times Cited: 2
Trace amine-associated receptor gene polymorphism increases drug craving in individuals with methamphetamine dependence
Jennifer M. Loftis, Michael Lasarev, Xiao Shi, et al.
PLoS ONE (2019) Vol. 14, Iss. 10, pp. e0220270-e0220270
Open Access | Times Cited: 20
Effects of a trace amine-associated receptor 1 agonist RO 5263397 on ethanol-induced behavioral sensitization
Ruyan Wu, Jianfeng Liu, Kaixuan Wang, et al.
Behavioural Brain Research (2020) Vol. 390, pp. 112641-112641
Open Access | Times Cited: 18
Trace amine-associated receptor 1 modulates motor hyperactivity, cognition, and anxiety-like behavior in an animal model of ADHD
Ícaro Raony, Ivan Domith, Mychael V. Lourenco, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 117, pp. 110555-110555
Closed Access | Times Cited: 11
Interaction analyses of hTAAR1 and mTAAR1 with antagonist EPPTB
Siyan Liao, Michael James Pino, Catherine Deleon, et al.
Life Sciences (2022) Vol. 300, pp. 120553-120553
Open Access | Times Cited: 11
Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer’s Disease
Damiana Leo, Giorgia Targa, Stefano Espinoza, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7811-7811
Open Access | Times Cited: 11
Regional Analysis of the Brain Transcriptome in Mice Bred for High and Low Methamphetamine Consumption
Robert Hitzemann, Ovidiu D. Iancu, Cheryl Reed, et al.
Brain Sciences (2019) Vol. 9, Iss. 7, pp. 155-155
Open Access | Times Cited: 19
Activation of trace amine‐associated receptor 1 selectively attenuates the reinforcing effects of morphine
Jianfeng Liu, Robert Seaman, Bernard Johnson, et al.
British Journal of Pharmacology (2020) Vol. 178, Iss. 4, pp. 933-945
Open Access | Times Cited: 17
Dopamine D2 Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders
Richard M. Kostrzewa, Karolina Wydra, Małgorzata Filip, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 366, Iss. 3, pp. 519-526
Open Access | Times Cited: 18
The selective TAAR1 partial agonist RO5263397 promoted novelty recognition memory in mice
Ruyan Wu, Jianfeng Liu, Robert Seaman, et al.
Psychopharmacology (2021) Vol. 238, Iss. 11, pp. 3221-3228
Open Access | Times Cited: 12
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats
Colleen Synan, Carrie A. Bowen, David J. Heal, et al.
Drug and Alcohol Dependence (2021) Vol. 231, pp. 109261-109261
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top